Clinical Trials Directory

Trials / Completed

CompletedNCT02295553

Ketamine and Propofol for Upper Endoscopy

Co-administration of Ketamine and Propofol for Upper Endoscopy in Children: a Dose-finding Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
56 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
3 Years – 13 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the dose-response relationship of ketamine in combination with propofol.

Detailed description

Direct visualization of the esophagus, stomach and small intestine is performed using a scope that is inserted while the patient is under under deep sedation or general anesthesia. The most common method of providing general anesthesia for upper endoscopy is intravenous administration of medications such as propofol, often in combination with other medications such as fentanyl, midazolam, remifentanil or ketamine. One study found that the combination of propofol and ketamine provides better conditions (less patient movement, more stable heart and breathing) but more side effects afterwards compared to propofol and fentanyl.

Conditions

Interventions

TypeNameDescription
DRUGKetamine
DRUGPropofol

Timeline

Start date
2013-07-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-11-20
Last updated
2019-06-10
Results posted
2019-06-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02295553. Inclusion in this directory is not an endorsement.